Profile picture

Doctor Antonio Abbate

University of Virginia, Charlottesville (United States of America)
Membership: FESC Member
Follow
Biography
Dr. Abbate received his Medical Degree from the University Campus Bio-Medico, and Cardiovascular Medicine training at the Catholic University of the Sacred Heart, Rome, Italy, and also earned a PhD in Molecular and Cellular Cardiology. He then moved to Richmond, Virginia, USA, and completed a Residency in Internal Medicine at the Virginia Commonwealth University and joined the faculty rising to the rank of Professor with tenure. In 2022, Dr. Abbate relocated to the University of Virginia in Charlottesville, VA, as the Ruth C. Heede Professor of Cardiology in the Berne Cardiovascular Research Center and Heart and Vascular Center. Dr. Abbate is board certified in Internal Medicine and Cardiovascular Medicine and Fellow of the American College of Cardiology, Fellow of American Heart Association, and Fellow of the European Society of Cardiology. Dr Abbate’s research focuses on cardio-immunology Dr. Abbate attends the coronary intensive care unit, general cardiology and cardio-oncology.
Logo ESC

Contributor content

Resolution of systemic inflammation in patients with recently decompensated heart failure with reduced ejection fraction with and without interleukin-1 blockade by anakinra
Presentation
Resolution of systemic inflammation in patients with recently decompensated heart failure with reduced ejection fraction with and without interleukin-1 blockade by anakinra
Diabetes mellitus and response to IL-1 blockade with Anakinra after ST-elevation myocardial infarction: a pooled analysis of the VCU-ART studies
Presentation
Diabetes mellitus and response to IL-1 blockade with Anakinra after ST-elevation myocardial infarction: a pooled analysis of the VCU-ART studies
Interleukin -1 inhibitors.
Presentation
Interleukin -1 inhibitors.
Interleukin-1 blockade with Anakinra in ST-segment elevation acute myocardial infarction: Results from the VCUART3 study
Presentation
Interleukin-1 blockade with Anakinra in ST-segment elevation acute myocardial infarction: Results from the VCUART3 study
Effects of Interleukin-1 blockade with Anakinra on cardiac function in ST-segment elevation acute myocardial infarction: results from the VCUART3 echocardiography study
Presentation
Effects of Interleukin-1 blockade with Anakinra on cardiac function in ST-segment elevation acute myocardial infarction: results from the VCUART3 echocardiography study

ESC 365 is supported by